Your browser doesn't support javascript.
loading
Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999.
Rapaport, Franck; Seier, Kenneth; Neelamraju, Yaseswini; Hassane, Duane; Baslan, Timour; Gildea, Daniel T; Haddox, Samuel; Lee, Tak; Murdock, H Moses; Sheridan, Caroline; Thurmond, Alexis; Wang, Ling; Carroll, Martin; Cripe, Larry D; Fernandez, Hugo; Mason, Christopher E; Paietta, Elisabeth; Roboz, Gail J; Sun, Zhuoxin; Tallman, Martin S; Zhang, Yanming; Gönen, Mithat; Levine, Ross; Melnick, Ari M; Kleppe, Maria; Garrett-Bakelman, Francine E.
Afiliação
  • Rapaport F; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Seier K; Center for Clinical and Translational Science, The Rockefeller University, New York, NY, USA.
  • Neelamraju Y; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hassane D; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.
  • Baslan T; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Gildea DT; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Haddox S; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.
  • Lee T; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.
  • Murdock HM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Sheridan C; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Thurmond A; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Wang L; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.
  • Carroll M; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Cripe LD; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Fernandez H; Simon Cancer Center, Indiana University, Indianapolis, IN, USA.
  • Mason CE; Department of Malignant Hematology & Cellular Therapy, Moffitt Cancer Center, Tampa, FL, USA.
  • Paietta E; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Roboz GJ; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Sun Z; The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, USA.
  • Tallman MS; Montefiore Medical Center, Bronx, NY, USA.
  • Zhang Y; Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY, USA.
  • Gönen M; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Levine R; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Melnick AM; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kleppe M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Garrett-Bakelman FE; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Blood Cancer J ; 13(1): 103, 2023 Jul 06.
Article em En | MEDLINE | ID: mdl-37407550

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos